Eliksa Therapeutics
3 known investors
Find your way into Eliksa Therapeutics
Sign up to see every warm intro you have to Eliksa Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Eliksa Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Eliksa Therapeutics develops innovative treatments for rare diseases with unmet medical needs.
Investors · 3
Militia Hill Ventures✓ confirmed by Eliksa TherapeuticsPhiladelphia
How we know: the company's own site · Not right? Tell us
Ben Franklin Technology Partners✓ confirmed by Eliksa TherapeuticsHarrisburg · $50K – $250K
How we know: the company's own site · Not right? Tell us
BioAdvancelisted by BioAdvanceConshohocken · $500K – $1.5M
How we know: BioAdvance's portfolio page · press coverage · funding news · Not right? Tell us
In the news
Frequently asked questions
- What does Eliksa Therapeutics do?
- Eliksa Therapeutics develops innovative treatments for rare diseases with unmet medical needs.
- Who are Eliksa Therapeutics's investors?
- Eliksa Therapeutics's investors include Militia Hill Ventures, Ben Franklin Technology Partners, BioAdvance.



